S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Health-Care Stocks Fall Less Than the Broad Market as Deals Emerge

Health-care companies declined amid a broad market drop, but their losses were smaller. Deal activity included Johnson & Johnson’s agreement to acquire Ollin Biosciences and Eli Lilly’s planned purchase of Calytrix Bio.

Health-Care Stocks Fall Less Than the Broad Market as Deals Emerge

Johnson & Johnson agreed to pay an initial $2.2 billion for biotech firm Ollin Biosciences. It also struck a deal with investment firm Blackstone to fund development of Ollin’s lead eye-care product candidate.

Eli Lilly agreed to pay up to $1.5 billion to acquire Calytrix Bio, a closely held biotechnology company backed by JPMorgan. Calytrix is developing treatments for a group of rare blood cancers.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!